RVMD | Revolution MedicinesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$194.23
+$6.06 (+3.22%)

Revolution Medicines (RVMD) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since Oct 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits above the 50 and the 200; on the daily it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $194.23 vs 50 $198.45 / 200 $156.73
Projection
No cross projected
Test
No active test
Last cross
Golden cross 2 Oct 2025 ยท projected 17 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $191.31 vs 50 $143.39 / 200 $62.72
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 29 Apr 2024 ยท projected 20 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $195.13 vs 50 $193.02 / 200 $192.91
Projection
Death cross projected in 1 bar
Test
No active test
Last cross
Golden cross 16 Sep 2025 ยท projected 24 bars out

Cross history

17
crosses on record since 2021
9 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Oct 2025Golden moderatedaily17 bars outNot tested
16 Sep 2025Golden4-hour24 bars outโ€”
23 Jul 2025Death4-hour21 bars outโ€”
27 May 2025Golden4-hour24 bars outโ€”
11 Feb 2025Deathdaily23 bars out2 bar cross test

About RVMD

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$349M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.